Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.750
-0.050 (-2.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
PALI's stock price has decreased by -80.47% in the past year and price targets may not have had time to catch up.
Palisade Bio Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$23.00
Upside
+1,214.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +2,071.43% | Nov 20, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 → $8 | Strong Buy | Maintains | $23 → $8 | +357.14% | Nov 13, 2024 |
| Maxim Group | Maxim Group | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,185.71% | May 1, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +1,185.71% | Apr 16, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $23 | Hold → Strong Buy | Upgrades | $23 | +1,185.71% | Nov 17, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $375 → $240 | Strong Buy | Maintains | $375 → $240 | +13,614.29% | May 16, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $750 | Hold → Strong Buy | Upgrades | $750 | +42,757.14% | Mar 30, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 19, 2022 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $3,750 | Strong Buy | Initiates | $3,750 | +214,185.71% | Feb 2, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $5,250 | Strong Buy | Initiates | $5,250 | +299,900.00% | Aug 31, 2021 |